Literature DB >> 5523460

[Hearing loss induced by the use of high doses of furosemide in the treatment of uremia].

A Heidland, M E Wigand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5523460     DOI： 10.1007/bf01497211

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  12 in total

1.  OTOLARYNGEAL PROBLEMS ARISING DURING THE MANAGEMENT OF SEVERE RENAL FAILURE.

Authors:  G P BEANEY
Journal:  J Laryngol Otol       Date:  1964-05       Impact factor: 1.469

2.  [STUDIES WITH THE SALURETIC 4-CHLORO-N-(2-FURYLMETHYL)-5-SULFAMOYLANTHRANILIC ACID. I].

Authors:  P HAJDU; A HAEUSSLER
Journal:  Arzneimittelforschung       Date:  1964-06

3.  STUDIES ON ETHACRYNIC ACID IN PATIENTS WITH REFRACTORY EDEMA.

Authors:  J F MAHER; G E SCHREINER
Journal:  Ann Intern Med       Date:  1965-01       Impact factor: 25.391

4.  Transient and permanent deafness following treatment with ethacrynic acid in renal failure.

Authors:  V K Pillay; F D Schwartz; K Aimi; R M Kark
Journal:  Lancet       Date:  1969-01-11       Impact factor: 79.321

5.  Active ion transport from the scala vestibuli into the scala media. Participation therein of Reissner's membrane and its blockade.

Authors:  J Prazma
Journal:  Acta Otolaryngol       Date:  1969-06       Impact factor: 1.494

6.  [Possibilities and limitations of high dosage diuretic therapy in hydropic renal insufficiency].

Authors:  A Heidland; K Klütsch; A Moormann; H Hennemann
Journal:  Dtsch Med Wochenschr       Date:  1969-08-01       Impact factor: 0.628

7.  Perceptive deafness in subjects with renal failure treated with haemodialysis and Polybrene. A clinico-pathological study.

Authors:  J Ransome; J C Bllantyne; S Shaldon; S K Bosher; C S Hallpike
Journal:  J Laryngol Otol       Date:  1966-07       Impact factor: 1.469

8.  Acute transient hearing loss after ethacrynic acid therapy.

Authors:  W J Schneider; E L Becker
Journal:  Arch Intern Med       Date:  1966-05

9.  [Renal excretion of the new diuretic Furosemide].

Authors:  J Gayer
Journal:  Klin Wochenschr       Date:  1965-08-15

10.  Ear, nose and throat manifestations in cases of renal failure treated by dialysis. Hemodialysis and peritoneal dialysis.

Authors:  A Yassin; F Safwat; A Fatt-Hi
Journal:  Ann Otol Rhinol Laryngol       Date:  1966-03       Impact factor: 1.547
View more
  7 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 2.  Drug-induced tinnitus and other hearing disorders.

Authors:  H Seligmann; L Podoshin; J Ben-David; M Fradis; M Goldsher
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

3.  Comparative acute ototoxicity of loop diuretic compounds.

Authors:  L P Rybak; C Whitworth; V Scott
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

Review 4.  Diuretics. II. Clinical considerations.

Authors:  J L Anderton; P Kincaid-Smith
Journal:  Drugs       Date:  1971       Impact factor: 9.546

5.  [Chemical examination of submandibular saliva in facial paralysis (author's transl)].

Authors:  P Bumm; M Berg; M Tiedtke
Journal:  Arch Otorhinolaryngol       Date:  1980

6.  Protective Effect of Mannitol on Cisplatin-Induced Nephrotoxicity: A Systematic Review and Meta-Analysis.

Authors:  Songtao Li; Xiuyun He; Linjie Ruan; Ting Ye; Yulong Wen; Zhihua Song; Siying Hu; Yu Chen; Bo Peng; Shijie Li
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

7.  Clinical pharmacology of furosemide in neonates: a review.

Authors:  Gian Maria Pacifici
Journal:  Pharmaceuticals (Basel)       Date:  2013-09-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.